Conclusions
ADVERSE EVENTS
In conclusion, we successfully demonstrated the feasibility of a MRI-guided daily online adaptive radiotherapy dose escalation approach triggered by an image based predictive response model. This approach resulted in a very favourable rate of ≥ G3 adverse events. The completion of enrollment in this clinical trial should therefore proceed as scheduled.